CM
RIGL icon

CM Management’s Rigel Pharmaceuticals RIGL Stock Holding History

CM Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.78M Buy
250,000
+15,000
+6% +$463K 6.21% 1
2026
Q1 		$6.35M Buy
235,000
+10,000
+4% +$336K 5.31% 2
2025
Q4 		$9.64M Hold
225,000
– – 8.12% 1
2025
Q3 		$6.37M Sell
225,000
-25,000
-10% -$748K 5.31% 3
2025
Q2 		$4.68M Hold
250,000
– – 4.26% 3
2025
Q1 		$4.5M Buy
250,000
+7,500
+3% +$152K 4.52% 4
2024
Q4 		$4.08M Sell
242,500
-47,500
-16% -$911K 3.64% 7
2024
Q3 		$4.69M Buy
+290,000
New +$3.41M 3.74% 5
2024
Q2 		– Sell
-200,000
Closed -$2.96M – 68
2024
Q1 		$2.96M Buy
200,000
+30,000
+18% +$404K 2.49% 13
2023
Q4 		$2.46M Buy
170,000
+20,000
+13% +$205K 1.98% 15
2023
Q3 		$1.62M Hold
150,000
– – 1.72% 18
2023
Q2 		$1.94M Hold
150,000
– – 1.89% 17
2023
Q1 		$1.98M Hold
150,000
– – 2.35% 12
2022
Q4 		$2.25M Buy
150,000
+20,000
+15% +$183K 2.69% 14
2022
Q3 		$1.53M Hold
130,000
– – 1.71% 20
2022
Q2 		$1.47M Buy
130,000
+52,500
+68% +$1.05M 1.56% 24
2022
Q1 		$2.32M Hold
77,500
– – 1.95% 16
2021
Q4 		$2.05M Buy
77,500
+2,500
+3% +$75.4K 1.55% 16
2021
Q3 		$2.72M Hold
75,000
– – 2.03% 12
2021
Q2 		$3.25M Buy
75,000
+25,000
+50% +$944K 2.35% 10
2021
Q1 		$1.71M Buy
50,000
+10,000
+25% +$396K 1.27% 23
2020
Q4 		$1.4M Buy
+40,000
New +$1.16M 1.3% 26

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CM Management's RIGL Position: Q2 2026 in Review

CM Management increased its Rigel Pharmaceuticals (RIGL) stake by 6.4% in Q2 2026, buying an estimated $463K and bringing the position to 250,000 shares worth $9.78M. The position accounts for 6.21% of the portfolio, ranked #1.

CM Management first reported a position in RIGL in Q4 2020 and has held it in 22 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • CM Management held 250,000 shares of Rigel Pharmaceuticals worth $9.78M as of Q2 2026.
  • CM Management bought 15,000 Rigel Pharmaceuticals shares in Q2 2026, an estimated $463K.
  • Rigel Pharmaceuticals made up 6.21% of CM Management's portfolio in Q2 2026, its #1 holding.
  • CM Management first reported a position in Rigel Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.